IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial

Bagot, M; Porcu, P; Marie-Cardine, A; Battistella, M; William, BM; Vermeer, M; Whittaker, S; Rotolo, F; Ram-Wolff, C; Khodadoust, MS; Bensussan, A; Paturel, C; Bonnafous, C; Sicard, H; Azim, HA; Kim, YH

Bagot, M (reprint author), Hop St Louis, F-75010 Paris, France.

LANCET ONCOLOGY, 2019; 20 (8): 1160

Abstract

Background IPH4102 is a first-in-class monoclonal antibody targeting KIR3DL2, a cell surface protein that is expressed in cutaneous T-cell lymphoma, a......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索